JP2016539119A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016539119A5 JP2016539119A5 JP2016533172A JP2016533172A JP2016539119A5 JP 2016539119 A5 JP2016539119 A5 JP 2016539119A5 JP 2016533172 A JP2016533172 A JP 2016533172A JP 2016533172 A JP2016533172 A JP 2016533172A JP 2016539119 A5 JP2016539119 A5 JP 2016539119A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- probiotic composition
- composition
- treatment
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361907076P | 2013-11-21 | 2013-11-21 | |
| US61/907,076 | 2013-11-21 | ||
| EP13306597.9 | 2013-11-21 | ||
| EP13306597.9A EP2876167A1 (en) | 2013-11-21 | 2013-11-21 | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment |
| PCT/IB2014/066249 WO2015075688A1 (en) | 2013-11-21 | 2014-11-21 | Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019221925A Division JP2020050664A (ja) | 2013-11-21 | 2019-12-09 | 化学療法に対する応答性のマーカーとしての微生物叢組成物、及び癌処置の有効性を改善するための微生物モジュレーター（プレ、プロ又はシンバイオティクス）の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016539119A JP2016539119A (ja) | 2016-12-15 |
| JP2016539119A5 true JP2016539119A5 (enExample) | 2017-12-28 |
| JP6662775B2 JP6662775B2 (ja) | 2020-03-11 |
Family
ID=49680948
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533172A Active JP6662775B2 (ja) | 2013-11-21 | 2014-11-21 | 化学療法に対する応答性のマーカーとしての微生物叢組成物、及び癌処置の有効性を改善するための微生物モジュレーター（プレ、プロ又はシンバイオティクス）の使用 |
| JP2019221925A Pending JP2020050664A (ja) | 2013-11-21 | 2019-12-09 | 化学療法に対する応答性のマーカーとしての微生物叢組成物、及び癌処置の有効性を改善するための微生物モジュレーター（プレ、プロ又はシンバイオティクス）の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019221925A Pending JP2020050664A (ja) | 2013-11-21 | 2019-12-09 | 化学療法に対する応答性のマーカーとしての微生物叢組成物、及び癌処置の有効性を改善するための微生物モジュレーター（プレ、プロ又はシンバイオティクス）の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10646521B2 (enExample) |
| EP (2) | EP2876167A1 (enExample) |
| JP (2) | JP6662775B2 (enExample) |
| KR (1) | KR102464342B1 (enExample) |
| CN (1) | CN106170557B (enExample) |
| AU (1) | AU2014351348B2 (enExample) |
| CA (1) | CA2931363C (enExample) |
| DK (1) | DK3071709T3 (enExample) |
| ES (1) | ES2764282T3 (enExample) |
| IL (2) | IL245751B (enExample) |
| PT (1) | PT3071709T (enExample) |
| SG (1) | SG10201803877YA (enExample) |
| WO (1) | WO2015075688A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016177682A1 (en) | 2015-05-06 | 2016-11-10 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| HK1253064A1 (zh) * | 2015-06-01 | 2019-06-06 | The University Of Chicago | 通过操纵共生微生物菌群对癌症的治疗 |
| EP3130680A1 (en) * | 2015-08-11 | 2017-02-15 | Universitat de Girona | Method for the detection, follow up and/or classification of intestinal diseases |
| DK4186927T3 (da) | 2015-10-21 | 2025-06-10 | Ose Immunotherapeutics | Fremgangsmåder og sammensætninger til at ændre makrofagers polarisering til pro-inflammatoriske celler til behandling af kræft |
| MA41013A (fr) * | 2015-11-20 | 2017-08-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
| CN106011281B (zh) * | 2016-07-19 | 2019-04-23 | 浙江大学 | 肠道分节丝状菌鞭毛蛋白的检测方法 |
| SG11201901726QA (en) * | 2016-09-16 | 2019-03-28 | Ubiome Inc | Method and system for panel characterizations |
| EP3518946A4 (en) | 2016-09-27 | 2020-09-09 | Board of Regents, The University of Texas System | METHODS TO IMPROVE IMMUNE CHECKPOINT BLOCKING TREATMENT BY MODULATING THE MICROBIOME |
| EP3559257A1 (en) * | 2016-12-22 | 2019-10-30 | Institut Gustave Roussy (IGR) | Microbiota composition, as a marker of responsiveness to anti-pd1/pd-l1/pd-l2 antibodies and use of microbial modulators for improving the efficacy of an anti-pd1/pd-l1/pd-l2 ab-based treatment |
| US11723935B2 (en) | 2017-02-06 | 2023-08-15 | New York University | Methods and compositions for treating and diagnosing pancreatic cancers |
| EP3378949A1 (en) * | 2017-03-22 | 2018-09-26 | Assistance Publique - Hôpitaux de Paris | Method for determining the potential efficacy of anticancer treatment |
| KR102563191B1 (ko) | 2017-07-05 | 2023-08-02 | 에벨로 바이오사이언시즈, 인크. | 비피도박테리움 애니멀리스 ssp. 락티스를 이용한 암 치료 조성물 및 방법 |
| BR112020002212A2 (pt) * | 2017-08-10 | 2020-07-28 | 4D Pharma Research Limited | composições compreendendo cepas bacterianas |
| EP3476396A1 (en) * | 2017-10-31 | 2019-05-01 | Institut Gustave Roussy | Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same |
| EP3505177A1 (en) * | 2017-12-29 | 2019-07-03 | Institut Gustave Roussy | Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer |
| CN107904298A (zh) * | 2017-12-29 | 2018-04-13 | 苏州普瑞森基因科技有限公司 | 一种用于分析肠道微生物的试剂盒及其应用 |
| JP2021512638A (ja) * | 2018-02-09 | 2021-05-20 | 学校法人慶應義塾 | Ｃｄ８＋ｔ細胞の誘導のための組成物および方法 |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| EP3597202A1 (en) * | 2018-07-20 | 2020-01-22 | Maat Pharma | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
| JP2021534091A (ja) * | 2018-08-05 | 2021-12-09 | ダ・ヴォルテッラ | 抗がん剤の有効性を改善する方法 |
| US11331269B2 (en) * | 2018-09-06 | 2022-05-17 | Massachusetts Institute Of Technology | Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment |
| EP3629023A1 (en) * | 2018-09-28 | 2020-04-01 | Institut Gustave Roussy | Microbiota composition, as a marker of responsiveness to anti-pd1/pd-l1/pd-l2 antibodies in renal cell cancer |
| AU2019384816A1 (en) | 2018-11-21 | 2021-06-24 | Board Of Regents, The University Of Texas System | Methods and compositions for treating cancer |
| KR20210111254A (ko) * | 2018-11-30 | 2021-09-10 | 캐리스 엠피아이, 아이엔씨. | 차세대 분자 프로파일링 |
| CN113166815B (zh) * | 2019-02-22 | 2024-06-11 | 深圳华大生命科学研究院 | 肠道宏基因组在筛选pd-1抗体阻断剂疗效方面的用途 |
| JP2022523564A (ja) | 2019-03-04 | 2022-04-25 | アイオーカレンツ， インコーポレイテッド | 機械学習を使用するデータ圧縮および通信 |
| EP3950929A4 (en) * | 2019-03-28 | 2023-01-04 | CJ Bioscience, Inc. | FAECALIBACTERIUM SP. MICROBE AND ANTI-CANCER COMPOSITION WITH IT |
| CN111991427A (zh) * | 2019-05-07 | 2020-11-27 | 瑞微（深圳）生物科技有限公司 | 肠道细菌在制备用于促进TCR γδ+T细胞增殖的药物中的应用 |
| AU2020269080A1 (en) * | 2019-05-08 | 2021-12-16 | Megan BARNET | Cancer stratification and treatment based on inhibition of NOD-2 |
| US12685743B2 (en) | 2019-10-01 | 2026-07-21 | New York University | Methods and compositions for treating and diagnosing pancreatic cancers |
| KR20220116438A (ko) * | 2019-11-01 | 2022-08-23 | 유티아이 리미티드 파트너쉽 | 암 치료를 위한 미생물총 및 대사산물의 힘 활용 |
| US20230002502A1 (en) * | 2019-11-26 | 2023-01-05 | South Australian Health And Medical Research Institute Limited | Methods and products for reducing side effects associated with use of immune agonist antibodies |
| IL293489A (en) * | 2019-12-02 | 2022-08-01 | Caris Mpi Inc | predictor of pan-cancer platinum response |
| CN114832088B (zh) * | 2022-05-19 | 2026-04-14 | 李臻 | 拉瑞唑来多肽在制备缓解阿霉素心脏毒性药物中的用途 |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
| CN116287355A (zh) * | 2023-05-12 | 2023-06-23 | 中国医学科学院北京协和医院 | 上消化道肿瘤化疗疗效及不良反应的肠道菌群预测模型 |
| CN116687981A (zh) * | 2023-07-21 | 2023-09-05 | 中山大学附属第六医院 | 一种益生菌混合制剂在制备缓解奥沙利铂化疗毒副作用制品中的应用及药物 |
| CN117237952B (zh) * | 2023-11-15 | 2024-02-09 | 山东大学 | 基于免疫地形图的染色病理切片细胞分布标注方法及系统 |
| CN120682997B (zh) * | 2025-06-23 | 2026-05-05 | 佳木斯大学 | 一株副格氏乳杆菌及其在防治肝癌的产品中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08295631A (ja) | 1995-02-27 | 1996-11-12 | Nichinichi Seiyaku Kk | 制癌増強剤 |
| JPH1029946A (ja) * | 1996-07-15 | 1998-02-03 | Nichinichi Seiyaku Kk | 液性免疫回復剤 |
| TW200904340A (en) * | 2007-05-11 | 2009-02-01 | Mannatech Inc | Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same |
| WO2010033425A2 (en) * | 2008-09-19 | 2010-03-25 | Nestec S.A. | Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| JP2012502998A (ja) | 2008-09-19 | 2012-02-02 | ネステク ソシエテ アノニム | 癌性腫瘍からの骨髄毒性を阻止又は軽減するための栄養支援 |
| JP5717116B2 (ja) * | 2008-12-22 | 2015-05-13 | 学校法人昭和大学 | 抗原特異的ヒトＴｈ１７細胞を調整する方法 |
| WO2011131472A1 (en) * | 2010-04-22 | 2011-10-27 | Institut Gustave Roussy | Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
-
2013
- 2013-11-21 EP EP13306597.9A patent/EP2876167A1/en not_active Withdrawn
-
2014
- 2014-11-21 US US15/038,073 patent/US10646521B2/en active Active
- 2014-11-21 DK DK14812648.5T patent/DK3071709T3/da active
- 2014-11-21 KR KR1020167016068A patent/KR102464342B1/ko active Active
- 2014-11-21 ES ES14812648T patent/ES2764282T3/es active Active
- 2014-11-21 CA CA2931363A patent/CA2931363C/en active Active
- 2014-11-21 CN CN201480063481.9A patent/CN106170557B/zh active Active
- 2014-11-21 EP EP14812648.5A patent/EP3071709B1/en active Active
- 2014-11-21 AU AU2014351348A patent/AU2014351348B2/en active Active
- 2014-11-21 PT PT148126485T patent/PT3071709T/pt unknown
- 2014-11-21 SG SG10201803877YA patent/SG10201803877YA/en unknown
- 2014-11-21 WO PCT/IB2014/066249 patent/WO2015075688A1/en not_active Ceased
- 2014-11-21 JP JP2016533172A patent/JP6662775B2/ja active Active
-
2016
- 2016-05-19 IL IL245751A patent/IL245751B/en active IP Right Grant
-
2019
- 2019-08-05 IL IL268526A patent/IL268526B/en unknown
- 2019-12-09 JP JP2019221925A patent/JP2020050664A/ja active Pending
-
2020
- 2020-04-21 US US16/854,117 patent/US11344586B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3468573T3 (fi) | Clostridium difficile -infektion hoito | |
| JP2019001815A5 (enExample) | ||
| NZ745678A (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
| JP2018199695A5 (enExample) | ||
| HRP20191344T1 (hr) | Sastavi koji sadrže bakterijske sojeve | |
| WO2016081518A3 (en) | Engineered gamma delta t-cells | |
| EP4417261A3 (en) | Bacteriotherapy | |
| HK1252759A1 (zh) | 肽寡核苷酸缀合物 | |
| MY151137A (en) | Probiotics to improve gut microbiota | |
| EP3904502A3 (en) | Compositions and methods | |
| NZ707328A (en) | Virus-containing formulation and use thereof | |
| JP2016501013A5 (enExample) | ||
| RU2018139655A (ru) | Бифидобактерии для увеличения безжировой массы тела | |
| NZ713423A (en) | Bacteriophage therapy | |
| HK1205939A1 (en) | Parenteral formulations for administering macrolide antibiotics | |
| RU2018139656A (ru) | Бифидобактерии для снижения потребления пищи, энергии и/или жиров | |
| JP2020513780A5 (enExample) | ||
| CN115052609A (zh) | 一种治疗癌症的细菌组合物 | |
| EA201390417A1 (ru) | Антидиабетические твердые фармацевтические композиции | |
| MX2025011566A (es) | Rotor para una turbomaquina generadora de energia, turbomaquina que comprende el rotor, y circuito termodinamico que usa la turbomaquina | |
| CN103861107B (zh) | 一种药物组合物及其用途 | |
| ATE536102T1 (de) | Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus | |
| RU2008129232A (ru) | Способ лечения туберкулеза легких у больных вич-инфекцией | |
| Srikanth et al. | Enhanced regression of tumors in mice with combined chemotherapy and immunotherapy | |
| Na et al. | Protective effect of Ginsan against Vibrio vulnificus infection |